New transplant method aims to tame deadly blood cancers with mismatched donors
NCT ID NCT02323867
Summary
This trial is testing a modified stem cell transplant for people with blood cancers like leukemia and lymphoma who don't have a perfectly matched donor. Doctors use a special process to remove certain immune cells from the donor's stem cells before the transplant. The goal is to help the patient's body accept the new cells with fewer dangerous side effects while still fighting the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.